On February 5, 2026, a paper with Assistant Professor Junichi Yamamoto as the first author was published in the international journal Scientific Reports. This study elucidated part of the molecular mechanism underlying the synergistic effects of pomalidomide (marketed as Pomalyst) and panobinostat (marketed as Farydak), two drugs used in the treatment of multiple myeloma, and

On August 10, 2025, a paper with Chayanin Wuttinontananchai, a doctoral student who completed the requirements for the Ph.D. program in March 2025, as the first author has been published in the international journal Scientific Reports. This study employed an sgRNA library screening approach to investigate the mechanisms underlying alternative polyadenylation during RNA polymerase II-mediated

The results of a joint research with Profs. Kurumozaka and Kujirai of the Institute for Quantitative Biosciences, the University of Tokyo and others have been published in the international journal Nature Communications. This paper presents a groundbreaking study in which RNA polymerase II complexes isolated by immunoprecipitation from a human cultured cell line were directly

The results of joint research with Dr. Noriyuki Azuma, Dr. Hiroshi Nishina, and colleagues at Tokyo Medical and Dental University and the National Center for Child Health and Development have been published in Genes to Cells, an international journal of molecular biology. This research focused on INTS15, a protein of unknown function that was speculated